J Korean Med Sci.  2003 Dec;18(6):876-880. 10.3346/jkms.2003.18.6.876.

Associations of Moyamoya Patients with HLA Class I and Class II Alleles in the Korean Population

Affiliations
  • 1Department of Microbiology and Immunology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • 2Department of Neurosurgery, College of Medicine, The Catholic University of Korea, Seoul, Korea. dalskim@cmc.cuk.ac.kr

Abstract

Moyamoya disease is characterized by progressive cerebrovascular occlusion at the peripheral internal carotid artery and development of abnormal collateral circulation at the cerebral basal region. Although abnormal thrombogenesis, inflammation and autoimmune process might be involved in the etiology, the genetic pathogenesis of Moyamoya disease is still unknown. To evaluate the association of Moyamoya disease with HLA alleles in the Korean population, we investigated HLA class I and class II alleles in 28 Moyamoya patients and 198 unrelated healthy controls. The frequency of HLA-B35 allele was significantly increased in the patients compared to the controls (32.1% vs. 10.1%, RR=4.2, p<0.008). Further analysis of HLA-B35 on onset age and sex showed that this allele was significantly increased compared to the controls in both late-onset and female group. Especially, HLA-B35 was the most significantly increased in female of late-onset group compared to the controls. These results suggest that HLA-B35 may be an useful genetic marker for Moyamoya disease, and particularly in females of late onset group in the Korean population.

Keyword

Moyamoya Disease; HLA-B Antigens; Female; Age of Onset; Korean

MeSH Terms

Adolescent
Adult
Age of Onset
Aged
Child
Child, Preschool
Female
Gene Frequency
*Genes, MHC Class I
*Genes, MHC Class II
Genetic Markers
Genetic Predisposition to Disease
Genotype
HLA Antigens/*genetics
Human
Korea
Male
Middle Aged
Moyamoya Disease/*genetics/*immunology
Retrospective Studies
Support, Non-U.S. Gov't

Cited by  5 articles

HLA and Disease Associations in Koreans
Stephen Ahn, Hee-Back Choi, Tai-Gyu Kim
Immune Netw. 2011;11(6):324-335.    doi: 10.4110/in.2011.11.6.324.

Case of Moyamoya Disease Aggravated during the Treatment of Behçet's Disease
Eun Seong Park, Yoon-Jeong Oh, Byung-Woo Yoo, Sung Soo Ahn, Jin Su Park, Pyeong Ho Yoon, Chan Hee Lee
J Rheum Dis. 2016;23(6):386-391.    doi: 10.4078/jrd.2016.23.6.386.

Moyamoya Biomarkers
Edward R. Smith
J Korean Neurosurg Soc. 2015;57(6):415-421.    doi: 10.3340/jkns.2015.57.6.415.

Single Nucleotide Polymorphism in Patients with Moyamoya Disease
Young Seok Park
J Korean Neurosurg Soc. 2015;57(6):422-427.    doi: 10.3340/jkns.2015.57.6.422.

A Recent Update of Clinical and Research Topics Concerning Adult Moyamoya Disease
Jin Pyeong Jeon, Jeong Eun Kim
J Korean Neurosurg Soc. 2016;59(6):537-543.    doi: 10.3340/jkns.2016.59.6.537.

Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr